MicroRNA MiR-214 Regulates Ovarian Cancer Cell Stemness by Targeting P53/nanog.

Cheng-Xiong Xu,Meng Xu,Lei Tan,Hua Yang,Jennifer Permuth-Wey,Patricia A. Kruk,Robert M. Wenham,Santo V. Nicosia,Johnathan M. Lancaster,Thomas A. Sellers,Jin Q. Cheng
DOI: https://doi.org/10.1074/jbc.m112.374611
IF: 5.485
2016-01-01
Journal of Biological Chemistry
Abstract:Previous studies have shown aberrant expression of miR-214 in human malignancy. Elevated miR-214 is associated with chemoresistance and metastasis. In this study, we identified miR-214 regulation of ovarian cancer stem cell (OCSC) properties by targeting p53/Nanog axis. Enforcing expression of miR-214 increases, whereas knockdown of miR-214 decreases, OCSC population and self-renewal as well as the Nanog level preferentially in wild-type p53 cell lines. Furthermore, we found that p53 is directly repressed by miR-214 and that miR-214 regulates Nanog through p53. Expression of p53 abrogated miR-214-induced OCSC properties. These data suggest the critical role of miR-214 in OCSC via regulation of the p53-Nanog axis and miR-214 as a therapeutic target for ovarian cancer.
What problem does this paper attempt to address?